To study the mechanism of action of this chemo-immunotherapeutic regimen, we further analyzed the immune cell landscape in the blood, spleen, lung and tumor focusing on the cytotoxic effector cells (CD8+T and NK cells) and immunosuppressive populations (MDSCs). Here, CD8A is linked to neoplasm.